AtriCure, Inc. (ATRC)
NGM · Common · CUSIP 04963C209
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ATRC and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
04963C209
Market Cap
Large Cap
Business: AtriCure, Inc. is a medical device company providing innovative atrial fibrillation (Afib) solutions designed to produce outcomes that reduce the economic and social burden of atrial fibrillation. AtriCure’s Synergy Ablation System is the first and only device approved for the treatment of Persistent and Longstanding Persistent forms of Afib in patients undergoing certain open concomitant procedures.

Company Contact

CEO
Michael H. Carrel
CFO
Angela L. Wirick
Headquarters
7555 Innovation Way, Mason, OH 45040
Phone
513-755-4100
Investor Relations
Lynn Pieper Lewis, Gilmartin Group · 415-937-5402 · lynn@gilmartinir.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »